Cost-effectiveness Analysis of Five Therapeutic Schemes for Female's Urogenital Tract Infections of Gon-ococcus Combining Chlamydia / 中国药房

ABSTRACT

OBJECTIVE:To discuss the economic effectiveness of different therapeutic schemes for the same disease.METH_ODS104 cases of female's urogenital tract infections of gonococcus combining chlamydia were randomly divided into five gro_ups,which were given ofloxacin(A),levofloxacin hydrochloride(B),clarithromycin(C),azithromycin(D)and ceftriaxone+erythromycin(E)respectively.Using pharmacoeconomic cost-effectiveness analysis method,the five schemes were compared.RES_ULTSThe costs of the five schemes were RMB 351,390,474,633 and 666 yuans,respectively.The ratios between cost and effectiveness were 5.7,4.5,5.5,7.6 and 8.3 in term of curative rate and 4.9,4.1,5.2,7.1 and 7.8 in term of effective rate respectively.CONCLUSION: B and C schemes are the best ones.